O'Dell Group’s Xeris Biopharma Holdings XERS Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q1 | – | Sell |
-3,316
| Closed | -$7.79K | – | 492 |
|
2023
Q4 | $7.79K | Buy |
+3,316
| New | +$7.79K | ﹤0.01% | 368 |
|
2023
Q3 | – | Sell |
-3,316
| Closed | -$8.69K | – | 499 |
|
2023
Q2 | $8.69K | Buy |
+3,316
| New | +$8.69K | ﹤0.01% | 355 |
|
2022
Q4 | – | Sell |
-3,316
| Closed | -$5K | – | 415 |
|
2022
Q3 | $5K | Hold |
3,316
| – | – | ﹤0.01% | 339 |
|
2022
Q2 | $5K | Buy |
+3,316
| New | +$5K | ﹤0.01% | 348 |
|
2021
Q4 | – | Sell |
-584
| Closed | -$1K | – | 554 |
|
2021
Q3 | $1K | Buy |
+584
| New | +$1K | ﹤0.01% | 479 |
|